Neurofibromatosis type 2

From WikiMD's Wellness Encyclopedia

Neurofibromatosis Type 2[edit | edit source]

Neurofibromatosis Type 2 (NF2) is a rare genetic disorder characterized by the development of noncancerous tumors in the nervous system, particularly affecting the brain and spinal cord. The hallmark of NF2 is the presence of bilateral vestibular schwannomas, which are tumors that develop on the vestibular nerves leading to the inner ear, causing hearing loss and balance issues.

Genetics[edit | edit source]

NF2 is caused by mutations in the NF2 gene, which is located on chromosome 22. This gene encodes a protein called merlin or schwannomin, which acts as a tumor suppressor. Mutations in the NF2 gene lead to a loss of function of merlin, resulting in uncontrolled cell growth and tumor formation. NF2 is inherited in an autosomal dominant pattern, meaning that a single copy of the mutated gene is sufficient to cause the disorder. However, about 50% of cases arise from a de novo mutation, meaning the mutation occurs spontaneously and is not inherited from a parent.

Symptoms[edit | edit source]

The symptoms of NF2 can vary widely among individuals but commonly include:

  • Hearing loss: Often the first symptom, due to vestibular schwannomas.
  • Tinnitus: Ringing in the ears.
  • Balance problems: Due to the effect on the vestibular nerves.
  • Cataracts: Early onset cataracts can occur in some individuals.
  • Skin tumors: Such as schwannomas and neurofibromas.
  • Meningiomas: Tumors that develop on the membranes covering the brain and spinal cord.

Diagnosis[edit | edit source]

Diagnosis of NF2 is based on clinical criteria and genetic testing. The presence of bilateral vestibular schwannomas is a key diagnostic criterion. MRI scans are used to detect tumors in the brain and spinal cord. Genetic testing can confirm mutations in the NF2 gene.

Treatment[edit | edit source]

There is no cure for NF2, and treatment focuses on managing symptoms and complications. Options include:

Prognosis[edit | edit source]

The prognosis for individuals with NF2 varies depending on the severity of the condition and the number and location of tumors. Regular monitoring and early intervention can help manage symptoms and improve quality of life.

Research[edit | edit source]

Ongoing research is focused on understanding the molecular mechanisms of NF2 and developing targeted therapies. Clinical trials are exploring new treatment options, including drugs that target specific pathways involved in tumor growth.

See Also[edit | edit source]

==

NIH genetic and rare disease info[edit source]

Neurofibromatosis type 2 is a rare disease.

WikiMD
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD